Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vision Biological Technology is a biotechnology company specializing in precision oncology and molecular diagnostics. Based in Suzhou Industrial Park, China, the company develops and manufactures high-performance diagnostic kits and platforms utilizing next-generation sequencing (NGS) and liquid biopsy technologies. Their product portfolio is primarily focused on the detection of somatic mutations in cancers such as non-small cell lung cancer and colorectal cancer, facilitating companion diagnostics and personalized treatment selection. Vision Biological Technology also provides services for minimal residual disease (MRD) monitoring and early cancer screening. The company aims to bridge the gap between genomic research and clinical application to improve patient management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vision Biological Technology.